Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana

Journal of Infection in Developing Countries

Volumn 7, Issue 1, 2013, Pages 41-45

  Kwamin, Francis ^a   Nartey, Nii Otu ^a   Codjoe, Francis S ^b   Newman, Mercy J ^a  

^a UNIVERSITY OF GHANA   (Ghana)

^b School of Allied Health Sciences   (Ghana)

Author keywords

Candidiasis; HIV AIDS; OPC; Resource limited countries

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; FEMALE; FUNGUS IDENTIFICATION; GHANA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OROPHARYNX CANDIDIASIS; SPECIES DISTRIBUTION;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA SAKE; CANDIDA TROPICALIS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84872415046     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2442     Document Type: Article

References (17)

1. Pfaller MA and Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public problem. Clin Microbiol Rev 20: 133-163.
2. Vazquez JA, Sobel JD (2003) Candidiasis. In Dismukes WE, Pappas PG, Sobel JD, editors. Clinical Mycology. New York: Oxford University Press. 143-187.
3. Hodgson TA and Rachanis CC (2002) Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa. Oral Dis 8: 80-87.
4. Kwamin F, Hewlett S, Ndanu TA, Lartey M, Nartey NO (2010) Incidence of orofacial lesions in relation to CD-4 Count in HIV/AIDS Patients at The Fevers Unit - Korle-Bu Teaching Hospital. Ghana Dental J 7: 22-26.
5. Klotz SA (2006) Oropharyngeal Candidiasis: A new treatment option. Clin Infect Dis 42: 1187-1188.
6. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America 1997-1998. Antimicrob Agents Chemother 44: 747-751.
7. National AIDS Control Programme. National HIV Prevalence and AIDS Estimates Report (2008-2015) Dis Control Unit-Ministry of Health, Accra, Ghana.
8. Nartey NO, Newman MJ, Kwamin F, Opintan JA (2006) The prevalence of oral candidiasis in HIV infection and acquired immune deficiency s yndrome. Ghana Dental J 6: 23-27.
9. Hamza OJ, Matee MIN, Moshi MJ, Simon ENM, Mugusi F, Mikx FHM, Helderman WHP, Rijs AJMM, Van der Ven AJAM, Verweij PE (2008) Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol 8: 135-144.
10. Patel M, Shackleton JT, Coogan MM (2006) Effect of antifungal treatment on the prevalence of yeasts in HIVinfected subjects. J Med Microbiol 55: 1279-1284.
11. Enwuru CA, Ogunledun A, Idika N, Enwuru NV (2008) Fluconazole resistant opportunistic oropharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinic in Lagos, Nigeria Afr Health Sci 8: 142-148.
12. Sullivan DJ, Moran G, Donnelly S, Gee S, Pinjon E, McCarton B, Shanley DB, Coleman DC (1999) Candida dubliniensis: an update. Rev Iberoam Microl 16: 72-76.
13. Binolfi A, Biasoli MS, Luque AG, Tosello ME, Magaro HM (2004) High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol 43: 431-437.
14. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF (2002) Replacement of C. albicans with C. dubliniensis in human immunodeficiencyvirus patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 40: 3135-3139.
15. Gutierrez J, Morales P, Gonzalez MA, Quindos G (2002) C. dubliniensis: a new fungal pathogen. J Basic Microbiol 42: 207-227
16. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM.(2007). Results from the ARTEMIS DISK Global antifungal surveillance study, 1997-2005: an 8.5-year analysis of susceptibilities of Candida species and other yeasts to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45: 1735-1745.
17. Wabe NT, Hussein J, Suleman S, Abdella K (2011) In vitro antifungal susceptibility of C. albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia. J Exp Integr Med 1: 265-271.